Bli medlem
Bli medlem

Du är här

2017-02-07

Lubrizol: Lubrizol LifeSciences to Showcase Expanded Medical Device Solutions at MD&M West 2017

News Release

Lubrizol LifeSciences to Showcase Expanded
Medical Device Solutions at MD&M West 2017

CLEVELAND, February 7, 2017 -The Lubrizol Corporation's LifeSciences business
will showcase its total solutions capabilities at the MD&M West 2017
Exposition
(Booth #2001), February 7-9 at the Anaheim Convention Center in Anaheim,
California. Lubrizol LifeSciences, along with its acquisitions Vesta and
Particle Sciences, is uniquely positioned as the only medical solutions
partner offering polymer customization, development services for drug eluting
devices and contract manufacturing services.

This year at MD&M West, Lubrizol LifeSciences will highlight new compounding
capabilities for Pellethane® TPU and Isoplast® ETPU products. Lubrizol's new
compounding offering includes color matching and custom colors for brand
recognition, safe identification, and aesthetics in medical device
applications, as well as compounding of radiopacifiers such as barium and
tungsten for X-ray identification and proper device positioning. This new
offering complements LifeSciences' portfolio of full service capabilities
enabling the simplification of customer's supply chain and ensuring success
in the medical device industry.

"When customers partner with Lubrizol LifeSciences, they benefit from working
with us at every stage in their development process," states Robert Miller,
general manager, Lubrizol LifeSciences. "With a long history of polymer
expertise and recent investments, Lubrizol LifeSciences is positioned to
offer full-service development for next generation medical and drug-eluting
device innovations."

To show further commitment to the medical and drug-eluting device markets,
Lubrizol LifeSciences has invested significantly to expand its global
development and manufacturing facilities, positioning Lubrizol to better
serve the growing market for medical device development and contract
manufacturing. This capital investment will expand multiple facilities and
increase Lubrizol LifeSciences' in-house engineering capacity for both
silicone and thermoplastic products. Part of this investment expands Vesta's
thermoplastic capabilities to include tip forming, tube flaring, pad
printing, hole punching/drilling, precision cutting, reflow, braided tubing
lamination and more.

Vesta offers custom contract manufacturing services, including precision
silicone and thermoplastic extrusion as well as comprehensive silicone
fabrication. With decades of experience, the company's service, engineering
expertise and commitment to quality are sought by customers worldwide.

- more -
About Lubrizol LifeSciences

Lubrizol LifeSciences is a healthcare solution partner that provides customer
support from idea to execution by supplying customizable polymers and
excipients, complex drug formulation development and best-in-class contract
manufacturing services for medical device and pharmaceutical manufacturers.
The combination of our polymer expertise, drug formulation development and
quality contract manufacturing allows Lubrizol LifeSciences to offer our
customers end-to-end solutions for success in the medical device and drug
delivery market.

About The Lubrizol Corporation

The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven
global company that combines complex, specialty chemicals to optimize the
quality, performance and value of customers' products while reducing their
environmental impact. It produces and supplies technologies to customers in
the global transportation, industrial and consumer markets. These
technologies include lubricant additives for engine oils, driveline and other
transportation-related fluids, industrial lubricants, as well as additives
for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and
additives for home care and personal care products and specialty materials
encompassing polymer and coatings technologies, along with polymer-based
pharmaceutical and medical device solutions. Our products for the oilfield
market include technologies for exploration, production and transportation.

With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing
facilities in 17 countries, as well as sales and technical offices around the
world. Founded in 1928, Lubrizol has approximately 9,000 employees
worldwide. Revenues for 2015 were $7 billion. For more information, visit
Lubrizol.com.

Vesta Inc. is part of Lubrizol Advanced Materials, Inc.

Pellethane® and Isoplast® are registered trademarks of The Lubrizol
Corporation.

Media Contact

Ben Patti
(216) 447-5827
www.lubrizol.com/LifeSciences
www.vestainc.com

###

---------------------------------------
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.